Patent · US Active

Protein kinase inhibitors

US9284318B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2012
Grant dateMar 15, 2016
Priority date
Expiry dateJul 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/147
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel kinase inhibitors. Compounds of this class have been found to be effective inhibitors of protein kinases, including members of PDGFR and VEGFR families.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.